| Addiction Treatment | |
| Alcohol | |
| Drugs | |
| Gambling | |
| In the papers | |
| On TV | |
New studies on the chemicals forming part of cannabis could improve knowledge of how the drug affects the mind, leading to more effective rehab therapy.
Professor Phillip McGuire, an author of the research from the Institute of Psychiatry at King's College London's, states their findings will further develop scientific understanding of the way the drug alter cognitive function.
Using functional magnetic resonance imaging and behavioural measures, the impact of active ingredients THC and CBD on the abilities of the subjects was assessed.
Mr McGuire states the results show these chemicals have "distinct effects" on the way the brain operates.
He says these "underlie" the various cognitive and psychiatric symptoms its use can create in people.
"Determining how the constituents of cannabis act on the brain is fundamental to understanding the role of cannabis use in the aetiology of psychiatric disorders," he claims.
In other news, the enrolment targets for the second phase of clinical trials for an anti-cocaine addiction drug have been reached.
CPP-109, a medicine based on vigabatrin, could also be used to treat methamphetamine dependency.
Bookmark this: